LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency’s commercial crew program even worse.
The Aerospace Safety Advisory Panel (ASAP), in a previously scheduled meeting at the Johnson Space Center Oct. 11 only hours after the Soyuz MS-10 spacecraft suffered a launch vehicle failure and had to make an emergency landing, said the incident only deepened concerns about the ability of Boeing and SpaceX to adhere to their schedules without jeopardizing safety.
“We have not seen the program make decisions detrimental to safety,” said Patricia Sanders, chair of ASAP, in her opening remarks. “But current projected schedules for uncrewed and crewed test flights for both providers have considerable risk and do not appear achievable.”
“The panel believes that an overconstrained schedule, driven by any real or perceived gap in astronaut transport to the International Space Station and possibly exacerbated by this morning’s events, poses a danger that sound engineering design solutions could be superseded, critical program content could be delayed or deleted, and decisions of ‘good enough to proceed’ could be made on insufficient data,” she argued.
Sanders and other ASAP members said they were skeptical that either Boeing or SpaceX could maintain its current schedules for fielding their commercial crew systems, let alone accelerate them to address a potential gap in ISS access created by the Soyuz failure.
ASAP member Don McErlean outlined several issues that SpaceX’s Crew Dragon spacecraft needs to overcome, including a lack of a final resolution on the root cause of the failure of a composite overwrapped pressure vessel (COPV) that led to the pad explosion of a Falcon 9 more than two years ago. That is linked, he added, to the use of “load-and-go” fueling of the rocket that would take place, on commercial crew missions, after astronauts have boarded the spacecraft.
“Ultimately, there has to be the acceptance and certification of a configuration which is judged by both parties to be free of the demonstrated characteristics that caused the failure in question,” he said. “This remains an open technical item that the panel believes has to be firmly resolved before we can certainly proceed to crewed launches.”
Image Credit: Boeing/SpaceX
News This Week
Study suggests people who have had COVID-19 benefit from vaccination, even if they’ve delayed it. Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers at [...]
The incorporation of exotic DNA from wild relatives into wheat results in a remarkable yield increase of up to 50%, even in hot weather, surpassing elite lines without these genes. Amid a year of [...]
Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people [...]
In a new study, scientists with the University of Florida have found that a combination of silver nanoparticles and antibiotics is effective against antibiotic-resistant bacteria. The researchers hope to turn this discovery into viable [...]
Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with [...]
According to a new study by researchers at Penn Medicine, ketamine, which is well-known as an anesthetic and is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if [...]
A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine [...]
An AI was tasked with creating proteins with anti-microbial properties. Researchers then created a subset of the proteins and found some did the job. An AI has designed anti-microbial proteins that were then tested [...]
Treating cancer with combinations of drugs can be more effective than using a single drug. However, figuring out the optimal combination of drugs, and making sure that all of the drugs reach the right [...]
By one unique metric, we could approach technological singularity by the end of this decade, if not sooner. A translation company developed a metric, Time to Edit (TTE), to calculate the time it takes for professional [...]
Phase transition in early universe changes strength of interaction between dark and normal matter. Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without [...]
Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of [...]
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The [...]
Using a mouse model, Japanese researchers unleash the likely mechanism of action of Actinidia arguta (sarunashi) juice on lung cancer development. Lung cancer is a leading cause of death in Japan and across the [...]
When used as wearable medical devices, stretchy, flexible gas sensors can identify health conditions or issues by detecting oxygen or carbon dioxide levels in the breath or sweat. They also are useful for monitoring [...]
Novel drugs, such as vaccines against covid-19, among others, are based on drug transport using nanoparticles. Whether this drug transport is negatively influenced by an accumulation of blood proteins on the nanoparticle’s surface was [...]